NUS Nu Skin Enterprises, Inc. Common Stock
NYSE · Consumer products · Ver em SEC EDGAR ↗ fechar Out 2, 2026 10-K/10-Q Ago 10, 2026NUS Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
NUS Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
Sobre Nu Skin Enterprises, Inc. Common Stock Visão geral da empresa da Wikipedia
Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors. The company was founded in 1984 by Blake Roney, Nedra Roney, Sandie Tillotson, and Steven J. Lund.
History
In 1984, Nu Skin founders Blake Roney, Nedra Roney, Sandie Tillotson, and Steven J. Lund launched a line of skincare products using only natural ingredients. The founders aimed to create skincare products and nutritional products without unnecessary fillers with the philosophy of “all of the good, none of the bad.”
The company first served the United States market and expanded operations to Canada in 1990. In 1991, the company began operations in Asia, starting in Hong Kong. In 1996, the company listed on the New York Stock Exchange.
In 1992, Nu Skin settled with five states that accused the company of deceptive advertising and overstating distributor income. In 1994, the company paid $1 million and signed a consent decree with the FTC prohibiting it from making deceptive product claims. In 1997, the company paid an additional $1.5 million to the FTC to settle allegations of unsubstantiated claims.
In 1998, Nu Skin acquired Generation Health, the parent company of the dietary supplement company Pharmanex. According to Women's Health Letter, the Pharmanex device was designed merely to help sell more supplements, since per Nu Skin's 2002 annual report, "as customers track their skin carotenoid content, we believe they will be motivated to consistently consume LifePak for longer periods of time."
In the late 1990s, Nu Skin invested in Big Planet, a multilevel marketing company selling Internet services. The New York Times wrote that Big Planet recruited people "even if they have little knowledge of the technology that they are supposed to be selling," with a Big Planet representative quoted: "I believe people who have never touched a computer before can become hugely wealthy in this business."
In 2009, Nu Skin began working with LifeGen Technologies, a genomics company based in Madison, Wisconsin. Nu Skin acquired LifeGen in December 2011. Nu Skin claims LifeGen's genetic database aided in the development of Nu Skin's products, launching the ageLOC brand.
In 2016, Nu Skin paid a $47 million class-action settlement, citing failure to disclose that its Chinese subsidiary did not register as the direct seller. Nu Skin paid $750k in fines to the United States Securities and Exchange Commission following allegations of a bribe that saw charity funds go to a Chinese politician.
In 2021, Nu Skin's subsidiary Rhyz Inc. acquired social commerce company Mavely and acquired Dallas-based skincare company BeautyBio in 2023. In 2025, the company sold the Mavely platform for five times what it paid for the company in 2021, in a $250 million transaction to Later, the Summit Partners company.
Products
Nu Skin was granted a patent on a device developed by Pharmanex called a "BioPhotonic Scanner", which is designed to measure the carotenoid level in skin. The company launched its ageLOC anti-aging brand in 2008.
In 2014, Nu Skin launched the Nu Skin Facial Spa which received FDA clearance for over-the-counter cosmetic use. In 2018, the company introduced the ageLOC LumiSpa, a dual-action skin care device that uses a soft silicone treatment head to gently cleanse away dirt, oil, and makeup.
Nu Skin launched ageLOC LumiSpa iO, the company's first connected device, in 2022. LumiSpa iO is a smart treatment and cleansing device for customized skin care, popularized by Venus Williams. Nu Skin launched Nu Colour “Lash + Brow” in 2023, marketed as free of prostaglandins. In 2022, Nu Skin launched a line of Nutricentials Bioadaptive Skin Care Pumps. In 2024, the company launched Nu Skin RenuSpa iO, an FDA-cleared microcurrent body device with a connected app to view live insights during treatment. RenuSpa iO is the company's first integrated beauty and wellness device. In 2024, Nu Skin launched MYND360 as a supplement and topicals product line for cognitive health.
Reception
Nu Skin Enterprises' is a multi-level marketing business. Each distributor markets products directly to potential customers and may also recruit and train customers to become distributors. Distributors are paid on the retail markup on products they are able to sell, as well as a performance bonus based on the sales of recruited distributors. In the early 1990s, Nu Skin was investigated by Connecticut, Pennsylvania, Florida, Illinois, Ohio, and Michigan over allegations of misleading marketing practices. In 1992 the company settled with five of the states, admitted no wrongdoing but agreed to pay the states' investigative costs, refund distributors, and revamp its promotional practices. The Connecticut Attorney General did not agree to those terms and sued Nu Skin, alleging the company misled its distributors and operated a pyramid scheme. Nu Skin admitted to no wrongdoing or violation of law and settled with the state for $85k for consumer-protection programs.
In 1997, the Attorney General of Pennsylvania alleged in a lawsuit that Nu Skin operated a pyramid scheme through a subsidiary, QIQ Connections and that distributors paid for the right to market technology services that did not, in fact, exist. Nu Skin discontinued the QIQ subsidiary, allowing those who had paid QIQ to move to Big Planet, a Nu Skin investment marketing Internet technology. The president of Big Planet described the allegations as a matter of "a few distributors who in their enthusiasm have been overzealous in some of their marketing activities."
In 2010, Nu Skin was listed among Forbes "100 Most Trustworthy Companies".
In 2011, two Utah-incorporated business entities linked to top executives of Nu Skin each made a $1 million contribution to Restore Our Future, a Super PAC established by former aides to U.S. presidential candidate Mitt Romney to support his bid for the White House.
In 2012, Stanford University apologized for an misunderstanding following a cease and desist letter sent to halt the use of the name of one of its researchers, Dr. Stuart Kim, in Nu Skin's advertising. Also in 2012, Citron Research issued a report "stating that Nu Skin's sales model on mainland China, the fastest growing market in direct-selling, amounted to an illegal multilevel marketing scheme." Nu Skin dismissed the claims, calling its sales model in China "kosher" and stating that it had no plans to change its business model. In 2014, The Chinese government investigated Nu Skin following a People's Daily newspaper report calling it a "suspected illegal pyramid scheme." Following the investigation, the Chinese government fined Nu Skin for $540k due to illegal sales and making false product claims.
In February 2014, a press release shows a class action lawsuit filed in the U.S. District Court for the District of Utah against Nu Skin Enterprises on behalf of investors who acquired stock of the company from July 2013, to January 2014.
In a Last Week Tonight with John Oliver segment that covered multilevel marketing companies, Oliver criticized Nu Skin for the fact that in 2015, 93% of its distributors did not earn a commission check in a typical month. Nu Skin says it pays approximately 43 percent of its product revenue in sales compensation.
In 2025, Nu Skin was named to USA Today's list of "best customer service."
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | NUS | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E (TTM) | -1.0média 5A ≈30.6 | ≈30.6 | · | · |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | NUS | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Margem Bruta (TTM) | 69.2%média 5A ≈70.6% | ≈70.6% | 68.4% | Fraco | |
| Margem Operacional (TTM) | -0.76%média 5A ≈2.4% | ≈2.4% | 2.4% | Fraco | |
| Margem EBITDA (TTM) | 2.9%média 5A ≈5.8% | ≈5.8% | 2.4% | Fraco | |
| Margem de Impostos Pré-Tributação (TTM) | -1.9%média 5A ≈3.4% | ≈3.4% | -2.0% | Fraco | |
| Margem de Lucro Líquido (TTM) | -15.7%média 5A ≈2.6% | ≈2.6% | -3.7% | Fraco | |
| ROA (TTM) | -16.9%média 5A ≈3.2% | ≈3.2% | 5.6% | Primeira linha | |
| ROE (TTM) | -32.5%média 5A ≈6.2% | ≈6.2% | 13.7% | Primeira linha | |
| ROIC | 5.2%média 5A ≈3.2% | ≈3.2% | 5.2% | Em linha |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | NUS | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido (MRQ) | 0.4média 5A ≈0.5 | ≈0.5 | 0.1 | Dívida alta | |
| Índice de liquidez corrente (MRQ) | 2.0média 5A ≈2.0 | ≈2.0 | 2.0 | Em linha | |
| Índice de Liquidez Seca (MRQ) | 0.9média 5A ≈0.9 | ≈0.9 | 0.6 | Liquidez forte | |
| Dívida de Longo Prazo / Patrimônio Líquido (MRQ) | 0.4média 5A ≈0.4 | ≈0.4 | · | · |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | NUS | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue YoY (Receita Ano a Ano) | -14.3%média 5A ≈-10.2% | ≈-10.2% | · | · | |
| Revenue CAGR 3Y (CAGR Receita 3A) | -12.6%média 5A ≈-11.7% | ≈-11.7% | · | · | |
| Revenue CAGR 5Y (CAGR Receita 5A) | -10.5% | · | · | · | |
| EPS YoY | -91.8%média 5A ≈-46.9% | ≈-46.9% | · | · | |
| Net Income YoY (Lucro Líquido Ano a Ano) | -91.8%média 5A ≈-47.9% | ≈-47.9% | · | · | |
| EPS CAGR 3Y (CAGR de LPA 3A) | 15.4% | · | · | · | |
| EPS CAGR 5Y (CAGR de LPA 5A) | -2.6% | · | · | · | |
| Net Income CAGR 3Y (CAGR de Lucro Líquido 3A) | 15.2% | · | · | · | |
| Net Income CAGR 5Y (CAGR de Lucro Líquido 5A) | -3.5% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | NUS | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Asset Turnover (Giro do Ativo) | 1.0média 5A ≈1.2 | ≈1.2 | 1.0 | Em linha | |
| Inventory Turnover (Giro de Estoque) | 2.5média 5A ≈2.1 | ≈2.1 | 3.1 | Fraco | |
| Receivables Turnover (Giro de Contas a Receber) | 32.9média 5A ≈39.8 | ≈39.8 | 15.7 | Primeira linha | |
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$530.4K | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Dividendos Rendimento, índice de pagamento, histórico de dividendos, CAGR de 5 anos
| Data ex | Valor | Moeda | Rendimento |
|---|---|---|---|
| Ago 28, 2026 | $0,06 | USD | ≈4.9% |
| Mai 29, 2026 | $0,06 | USD | ≈4.1% |
| Fev 27, 2026 | $0,06 | USD | ≈2.8% |
| Nov 28, 2025 | $0,06 | USD | ≈2.4% |
| Ago 29, 2025 | $0,06 | USD | ≈2.0% |
| Mai 30, 2025 | $0,06 | USD | ≈2.8% |
| Fev 24, 2025 | $0,06 | USD | ≈3.1% |
| Nov 29, 2024 | $0,06 | USD | ≈3.3% |
| Ago 30, 2024 | $0,06 | USD | ≈6.4% |
| Mai 31, 2024 | $0,06 | USD | ≈6.7% |
| Fev 23, 2024 | $0,06 | USD | ≈9.8% |
| Nov 22, 2023 | $0,39 | USD | ≈9.2% |
| Ago 24, 2023 | $0,39 | USD | ≈6.7% |
| Mai 25, 2023 | $0,39 | USD | ≈4.5% |
| Fev 24, 2023 | $0,39 | USD | ≈3.8% |
| Nov 23, 2022 | $0,39 | USD | ≈4.0% |
| Ago 25, 2022 | $0,39 | USD | ≈3.5% |
| Mai 26, 2022 | $0,39 | USD | ≈3.4% |
| Fev 25, 2022 | $0,39 | USD | ≈3.2% |
| Nov 24, 2021 | $0,38 | USD | ≈3.3% |
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | Ago 5, 2026 | $0.20 | $0.20 | -0.99% |
| 31 de Março de 2026 | $0.14 | $0.15 | -7.6% | |
| 31 de Dezembro de 2025 | $0.29 | $0.30 | -4.3% | |
| 30 de Setembro de 2025 | $0.34 | $0.30 | 12.2% | |
| 30 de Junho de 2025 | $0.43 | $0.25 | 73.7% | |
| 31 de Março de 2025 | $0.23 | $0.13 | 73.8% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49B | $1.73B | $1.97B | $2.23B | $2.70B | $2.58B | $2.42B | $2.68B | $2.28B | $2.21B | $2.25B | |
| Cost of Revenue | $454M | $550M | $612M | $631M | $675M | $658M | $581M | $634M | $502M | $500M | $490M | |
| Gross Profit | $1.03B | $1.18B | $1.36B | $1.59B | $2.02B | $1.92B | $1.84B | $2.04B | $1.78B | $1.71B | $1.76B | |
| R&D Expense | $11M | $13M | $23M | $23M | $27M | $23M | $30M | $23M | $22M | $24M | $20M | |
| SG&A Expense | $432M | $479M | $547M | $556M | $654M | $636M | $616M | $662M | $565M | $554M | $561M | |
| Operating Expenses | $966M | $1.33B | $1.31B | $1.48B | $1.79B | $1.67B | $1.57B | $1.80B | $1.50B | $1.48B | $1.51B | |
| Operating Income | $66M | $-152M | $48M | $111M | $234M | $258M | $267M | $241M | $274M | $231M | $245M | |
| Interest Expense | · | · | $26M | $14M | $11M | $13M | $19M | $22M | $22M | $16M | $8M | |
| Other Non-op | $-32M | $3M | $4M | $-8M | $-2M | $-1M | $-12M | $-21M | $-9M | $-18M | $-33M | |
| Pretax Income | $196M | $-175M | $27M | $89M | $232M | $256M | $255M | $220M | $266M | $213M | $212M | |
| Income Tax | $36M | $-28M | $18M | $-16M | $85M | $65M | $82M | $98M | $136M | $70M | $79M | |
| Net Income | $160M | $-147M | $9M | $105M | $147M | $191M | $174M | $122M | $129M | $143M | $133M | |
| EPS (Basic) | $3.25 | $-2.95 | $0.17 | $2.10 | $2.93 | $3.66 | $3.13 | $2.21 | $2.45 | $2.58 | $2.29 | |
| EPS (Diluted) | $3.18 | $-2.95 | $0.17 | $2.07 | $2.86 | $3.63 | $3.10 | $2.16 | $2.36 | $2.55 | $2.25 | |
| Shares (Basic) | 49,293,000 | 49,662,000 | 49,711,000 | 50,002,000 | 50,193,000 | 52,296,000 | 55,518,000 | 55,170,000 | 52,806,000 | 55,412,000 | 57,997,000 | |
| Shares (Diluted) | 50,301,000 | 49,662,000 | 49,860,000 | 50,525,000 | 51,427,000 | 52,765,000 | 55,927,000 | 56,476,000 | 54,852,000 | 56,097,000 | 59,057,000 | |
| EBITDA | $118M | $-82M | $119M | $183M | $310M | $332M | $344M | $324M | $346M | · | $316M |
Balanço Patrimonial
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $239M | $187M | $256M | $265M | $340M | $403M | $336M | $387M | $426M | $357M | $289M | |
| Short-term Investments | $1M | $11M | $12M | $14M | $15M | $21M | $8M | $11M | $12M | $11M | $14M | |
| Receivables | $40M | $51M | $59M | $47M | $41M | $63M | $50M | · | · | · | · | |
| Inventory | $179M | $190M | $280M | $346M | $400M | $314M | $276M | $296M | $253M | $250M | $265M | |
| Prepaid Expense | $90M | $73M | $81M | $88M | $77M | $102M | $70M | $52M | $53M | $65M | $102M | |
| Other Current Assets | $13M | $14M | $18M | $18M | $18M | $15M | $16M | $16M | $14M | $13M | $14M | |
| Current Assets | $548M | $539M | $702M | $760M | $873M | $903M | $740M | $799M | $778M | $714M | $706M | |
| PP&E (Net) | $377M | $380M | $433M | $445M | $454M | $468M | $454M | $465M | $465M | $445M | $455M | |
| PP&E (Gross) | $768M | $733M | $788M | $787M | $819M | $818M | $785M | $788M | $751M | $678M | $666M | |
| Accum. Depreciation | $391M | $353M | $355M | $342M | $366M | $350M | $331M | $323M | $286M | $234M | $212M | |
| Goodwill | $84M | $84M | $218M | $206M | $206M | $203M | $197M | $197M | $115M | $115M | $112M | |
| Intangibles | $43M | $74M | $95M | $67M | $77M | $90M | $80M | $90M | $68M | $64M | $67M | |
| Other Non-current Assets | $280M | $298M | $248M | $244M | $175M | $138M | $154M | $144M | $165M | $136M | $165M | |
| Total Assets | $1.41B | $1.47B | $1.81B | $1.82B | $1.91B | $1.96B | $1.77B | $1.69B | $1.59B | $1.47B | $1.51B | |
| Accounts Payable | $26M | $35M | $43M | $54M | $50M | $66M | $39M | $48M | $50M | $41M | $29M | |
| Accrued Liabilities | $218M | $218M | $254M | $280M | $372M | $447M | $290M | $323M | $319M | $275M | $311M | |
| Current Liabilities | $264M | $297M | $329M | $359M | $530M | $543M | $357M | $440M | $447M | $399M | $408M | |
| Capital Leases | $58M | $58M | $71M | $77M | $89M | $112M | $106M | $0 | · | · | · | |
| Deferred Tax | $310.0K | $345.0K | $522.0K | $439.0K | $2M | $626.0K | $11M | $18M | $37M | $643.0K | $16M | |
| Other Non-current Liabilities | $75M | $97M | $107M | $110M | $106M | $102M | $97M | $112M | $127M | $77M | $91M | |
| Total Liabilities | $600M | $817M | $987M | $924M | $994M | $1.06B | $894M | $913M | $885M | $810M | $680M | |
| Long-term Debt | $224M | $394M | $503M | $402M | $376M | $335M | $362M | $430M | $389M | $417M | $254M | |
| Total Debt | $224M | $394M | $503M | $402M | $376M | $335M | $362M | $430M | $389M | · | $250M | |
| Common Stock | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | |
| Retained Earnings | $1.86B | $1.71B | $1.87B | $1.94B | $1.91B | $1.84B | $1.73B | $1.64B | $1.61B | $1.56B | $1.49B | |
| Treasury Stock | $1.58B | $1.56B | $1.57B | $1.57B | $1.53B | $1.46B | $1.32B | $1.33B | $1.30B | $1.25B | $1.02B | |
| AOCI | $-116M | $-125M | $-100M | $-87M | $-74M | $-65M | $-85M | $-80M | $-66M | $-84M | $-71M | |
| Stockholders' Equity | $805M | $651M | $822M | $897M | $913M | $894M | $875M | $782M | $705M | $664M | $826M | |
| Liabilities + Equity | $1.41B | $1.47B | $1.81B | $1.82B | $1.91B | $1.96B | $1.77B | $1.69B | $1.59B | $1.47B | $1.51B |
Fluxo de Caixa
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $52M | $70M | $71M | $73M | $76M | $74M | $77M | $83M | $72M | $72M | $71M | |
| Stock-based Comp | $24M | $15M | $16M | $12M | $23M | $24M | $10M | $27M | $19M | $9M | $7M | |
| Deferred Tax | $20.0K | $-55M | $-15M | $-51M | $6M | $-14M | $-288.0K | $-19M | $44M | $-181.0K | $21M | |
| Amort. of Intangibles | $7M | $12M | $12M | $10M | $12M | $10M | $13M | $18M | $8M | $8M | $9M | |
| Restructuring | · | · | · | · | · | · | $22M | $22M | · | · | · | |
| Other Non-cash | $-156M | $229M | $39M | $-30M | $-112M | $104M | $-82M | $-10M | $38M | · | $90M | |
| Operating Cash Flow | $80M | $112M | $119M | $108M | $142M | $379M | $178M | $203M | $303M | $275M | $322M | |
| CapEx | $34M | $42M | $58M | $59M | $69M | $64M | $66M | $70M | $60M | $50M | $57M | |
| Investing Cash Flow | $171M | $-38M | $-135M | $-67M | $-89M | $-79M | $-71M | $-109M | $-92M | $-58M | $-61M | |
| Debt Issued | $55M | $15M | $110M | $460M | $155M | $115M | $145M | $582M | $67M | $234M | $36M | |
| Net Debt Issued | $-170M | $-110M | $100M | $28M | $40M | $-28M | $-69M | $30M | $-36M | · | $36M | |
| Stock Repurchased | $20M | $0 | $13M | $70M | $80M | $144M | $825.0K | $70M | $72M | $247M | $164M | |
| Net Stock Activity | $-20M | $0 | $-13M | $-70M | $-80M | $-144M | $-825.0K | $-70M | $-72M | · | $-164M | |
| Dividends Paid | $12M | $12M | $78M | $77M | $76M | $78M | $82M | $81M | $76M | $78M | $81M | |
| Financing Cash Flow | $-202M | $-133M | $11M | $-100M | $-105M | $-245M | $-155M | $-117M | $-160M | $-135M | $-236M | |
| Net Change in Cash | $52M | $-69M | $-9M | $-75M | $-63M | $67M | $-51M | $-39M | $69M | $68M | $939.0K | |
| Taxes Paid | $41M | $30M | $32M | $42M | $96M | $56M | $98M | $123M | $78M | $123M | $50M | |
| Free Cash Flow | $46M | $70M | $60M | $49M | $73M | $315M | $112M | $132M | $242M | · | $265M | |
| Levered FCF | · | · | $52M | $33M | $66M | $306M | $99M | $120M | $232M | · | $261M |
Lucratividade
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.5% | 68.2% | 68.9% | 71.7% | 75.0% | 74.5% | 76.0% | 76.3% | 78.0% | · | · | |
| Operating Margin | 4.4% | -8.8% | 2.5% | 5.0% | 8.7% | 10.0% | 11.1% | 9.0% | 12.0% | · | · | |
| Net Margin | 10.8% | -8.5% | 0.44% | 4.7% | 5.5% | 7.4% | 7.2% | 4.5% | 5.7% | · | · | |
| Pretax Margin | 13.2% | -10.1% | 1.4% | 4.0% | 8.6% | 9.9% | 10.5% | 8.2% | 11.7% | · | · | |
| EBITDA Margin | 8.0% | -4.7% | 6.0% | 8.2% | 11.5% | 12.8% | 14.2% | 12.1% | 15.2% | · | · | |
| ROA | 11.2% | -8.9% | 0.47% | 5.6% | 7.6% | 10.3% | 10.0% | 7.4% | 8.5% | · | 8.5% | |
| ROE | 22.0% | -19.9% | 1.0% | 11.6% | 16.3% | 21.6% | 20.9% | 16.4% | 18.9% | · | 15.0% | |
| ROIC | 5.2% | -12.2% | 1.2% | 10.0% | 11.5% | 15.6% | 14.7% | 11.0% | 12.2% | · | 14.3% |
Liquidez e Solvência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 1.8 | 2.1 | 2.1 | 1.6 | 1.7 | 2.1 | 1.8 | 1.7 | · | 1.7 | |
| Quick Ratio | 1.1 | 0.8 | 1.0 | 0.9 | 0.7 | 0.9 | 1.0 | 0.9 | 1.0 | · | 0.7 | |
| Debt / Equity | 0.3 | 0.6 | 0.6 | 0.4 | 0.4 | 0.4 | 0.4 | 0.6 | 0.6 | · | 0.3 | |
| LT Debt / Equity | 0.3 | 0.6 | 0.6 | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 | 0.4 | · | 0.2 | |
| Interest Coverage | · | · | 1.9 | 8.2 | 21.3 | 19.7 | 13.9 | 11.0 | 12.4 | · | 31.0 |
Eficiência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 1.1 | 1.1 | 1.2 | 1.4 | 1.4 | 1.4 | 1.6 | 1.5 | · | · | |
| Inventory Turnover | 2.5 | 2.3 | 2.0 | 1.7 | 1.9 | 2.2 | 2.0 | 2.3 | 2.0 | · | 1.6 | |
| Receivables Turnover | 32.9 | 31.6 | 32.8 | 50.2 | 51.5 | 45.4 | · | · | · | · | · |
Por Ação
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $29.53 | $34.88 | $39.49 | $44.05 | $52.42 | $48.93 | $43.28 | $47.44 | $41.55 | · | · | |
| Cash Flow / Share | $1.60 | $2.25 | $2.38 | $2.14 | $2.75 | $7.19 | $3.18 | $3.59 | $5.52 | · | $5.45 | |
| Dividend Paid / Share | · | · | · | · | · | · | · | · | · | · | $0.35 | |
| EPS (TTM) | $3.18 | $-2.95 | $0.17 | $2.07 | $2.86 | $3.63 | $3.10 | $2.16 | $2.36 | · | $2.25 |
Taxas de Crescimento
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -14.3% | -12.0% | -11.5% | -17.4% | 4.4% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -12.6% | -13.7% | -8.6% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -10.5% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | -91.8% | -27.6% | -21.2% | · | · | · | · | · | · | |
| EPS CAGR 3Y | 15.4% | · | -63.9% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -2.6% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | -91.8% | -28.8% | -23.0% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 15.2% | · | -64.5% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -3.5% | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | -31.5% | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.49B | $1.73B | $1.97B | $2.23B | $2.70B | $2.58B | $2.42B | $2.68B | $2.28B | · | $2.25B | |
| Net Income TTM | $160M | $-147M | $9M | $105M | $147M | $191M | $174M | $122M | $129M | · | $133M | |
| P/E | 3.0 | -2.3 | 114.2 | 20.4 | 17.7 | 15.0 | 13.2 | 28.4 | 28.9 | · | 16.8 | |
| Earnings Yield | 33.1% | -42.8% | 0.88% | 4.9% | 5.6% | 6.6% | 7.6% | 3.5% | 3.5% | · | 5.9% | |
| Payout Ratio | 7.4% | -8.1% | 903.1% | 73.5% | 51.8% | 41.0% | 47.4% | 66.1% | 58.8% | · | 61.0% | |
| Annual Payout | $12M | $12M | $78M | $77M | $76M | $78M | $82M | $81M | $76M | · | $81M |
Demonstração de Resultados
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $320M | $321M | $370M | $364M | $386M | $364M | $446M | $430M | $439M | $417M | $489M | $499M | $500M | $481M | $522M | $538M | |
| Cost of Revenue | $102M | $106M | $108M | $107M | $120M | $118M | $166M | $129M | $132M | $123M | $136M | $207M | $136M | $134M | $148M | $174M | |
| Gross Profit | $218M | $214M | $262M | $257M | $266M | $247M | $279M | $301M | $307M | $294M | $352M | $292M | $365M | $348M | $375M | $364M | |
| SG&A Expense | $91M | $99M | $107M | $105M | $107M | $113M | $121M | $116M | $118M | $125M | $145M | $131M | $137M | $134M | $128M | $138M | |
| Operating Expenses | $278M | $210M | $239M | $235M | $235M | $257M | $332M | $283M | $433M | $285M | $336M | $319M | $322M | $332M | $347M | $385M | |
| Operating Income | $-59M | $4M | $23M | $22M | $31M | $-10M | $-53M | $18M | $-126M | $9M | $16M | $-26M | $43M | $16M | $27M | $-20M | |
| Interest Expense | · | · | · | · | · | · | · | $6M | $7M | $7M | · | $8M | $6M | $5M | · | · | |
| Other Non-op | $-534.0K | $3M | $-1M | $-2M | $-843.0K | $-28M | $1M | $2M | $629.0K | $-396.0K | $633.0K | $-551.0K | $376.0K | $3M | $10M | $-9M | |
| Pretax Income | $-63M | $3M | $18M | $16M | $27M | $135M | $-58M | $13M | $-132M | $1M | $9M | $-34M | $37M | $15M | $24M | $-29M | |
| Income Tax | $187M | $763.0K | $4M | $-1M | $6M | $27M | $-22M | $5M | $-13M | $2M | $2M | $3M | $10M | $3M | $-33M | $-4M | |
| Net Income | $-250M | $2M | $14M | $17M | $21M | $108M | $-36M | $8M | $-118M | $-533.0K | $7M | $-37M | $27M | $11M | $57M | $-25M | |
| EPS (Basic) | $-5.14 | $0.04 | $0.31 | $0.35 | $0.43 | $2.16 | $-0.73 | $0.17 | $-2.38 | $-0.01 | $0.14 | $-0.74 | $0.54 | $0.23 | $1.16 | $-0.51 | |
| EPS (Diluted) | $-5.14 | $0.04 | $0.27 | $0.34 | $0.43 | $2.14 | $-0.73 | $0.17 | $-2.38 | $-0.01 | $0.14 | $-0.74 | $0.54 | $0.23 | $1.15 | $-0.51 | |
| Shares (Basic) | 48,596,000 | 48,202,000 | · | 49,398,000 | 49,441,000 | 49,764,000 | · | 49,707,000 | 49,688,000 | 49,538,000 | · | 49,859,000 | 49,931,000 | 49,644,000 | · | 50,199,000 | |
| Shares (Diluted) | 48,596,000 | 49,422,000 | · | 50,310,000 | 49,499,000 | 50,328,000 | · | 49,733,000 | 49,688,000 | 49,538,000 | · | 49,859,000 | 50,161,000 | 50,058,000 | · | 50,199,000 | |
| EBITDA | $-47M | $16M | · | $34M | $44M | $4M | · | $36M | $-108M | $27M | · | $-8M | $60M | $33M | · | $-2M |
Balanço Patrimonial
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $190M | $199M | $239M | $252M | $264M | $204M | $187M | $228M | $224M | $213M | · | $233M | $236M | $230M | · | $294M | |
| Short-term Investments | $2M | $2M | $1M | $1M | $1M | $10M | $11M | $10M | $9M | $9M | · | $17M | $17M | $17M | · | $14M | |
| Receivables | $49M | $45M | $40M | $49M | $60M | $57M | $51M | $69M | $72M | $67M | · | $77M | $67M | $60M | · | $48M | |
| Inventory | $191M | $179M | $179M | $179M | $180M | $189M | $190M | $248M | $244M | $265M | · | $291M | $372M | $367M | · | $327M | |
| Prepaid Expense | $76M | $99M | $90M | $68M | $66M | $66M | $73M | $99M | $106M | $94M | · | $83M | $101M | $100M | · | $94M | |
| Other Current Assets | · | · | $13M | · | · | · | $14M | · | · | · | · | · | · | · | · | · | |
| Current Assets | $508M | $523M | $548M | $548M | $572M | $525M | $539M | $653M | $654M | $647M | · | $701M | $793M | $774M | · | $778M | |
| PP&E (Net) | $380M | $382M | $377M | $375M | $374M | $380M | $380M | $411M | $412M | $423M | · | $429M | $430M | $438M | · | $433M | |
| PP&E (Gross) | · | · | $768M | · | · | · | $733M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $391M | · | · | · | $353M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $5M | $84M | $84M | $84M | $84M | $84M | $84M | $100M | $100M | $231M | · | $229M | $229M | $206M | · | $206M | |
| Intangibles | $38M | $39M | $43M | $44M | $46M | $48M | $74M | $85M | $88M | $102M | · | $109M | $113M | $65M | · | $69M | |
| Other Non-current Assets | $126M | $279M | $280M | $293M | $291M | $276M | $298M | $248M | $243M | $246M | · | $238M | $234M | $243M | · | $172M | |
| Total Assets | $1.12B | $1.38B | $1.41B | $1.42B | $1.44B | $1.39B | $1.47B | $1.58B | $1.59B | $1.74B | · | $1.79B | $1.89B | $1.82B | · | $1.76B | |
| Accounts Payable | $38M | $29M | $26M | $29M | $29M | $34M | $35M | $33M | $36M | $32M | · | $49M | $50M | $49M | · | $42M | |
| Accrued Liabilities | $199M | $208M | $218M | $206M | $220M | $207M | $218M | $247M | $242M | $247M | · | $245M | $256M | $276M | · | $281M | |
| Current Liabilities | $256M | $257M | $264M | $254M | $284M | $260M | $297M | $339M | $309M | $309M | · | $434M | $445M | $373M | · | $366M | |
| Capital Leases | $50M | $54M | $58M | $62M | $62M | $62M | $58M | $68M | $70M | $74M | · | $68M | $74M | $79M | · | $78M | |
| Deferred Tax | · | · | $310.0K | · | · | · | $345.0K | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $79M | $68M | $75M | $99M | $96M | $96M | $97M | $95M | $93M | $95M | · | $106M | $111M | $108M | · | $95M | |
| Total Liabilities | $579M | $583M | $600M | $625M | $656M | $637M | $817M | $876M | $900M | $932M | · | $971M | $998M | $932M | · | $921M | |
| Long-term Debt | $214M | $224M | $224M | $229M | $249M | $239M | $394M | $433M | $458M | $483M | · | $503M | $508M | $420M | · | $425M | |
| Total Debt | $214M | $224M | · | $229M | $249M | $239M | · | $433M | $458M | $483M | · | $503M | $508M | $420M | · | $425M | |
| Common Stock | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | · | $91.0K | $91.0K | $91.0K | · | $91.0K | |
| Retained Earnings | $1.61B | $1.86B | $1.86B | $1.85B | $1.83B | $1.82B | $1.71B | $1.75B | $1.75B | $1.87B | · | $1.88B | $1.94B | $1.93B | · | $1.90B | |
| Treasury Stock | $1.56B | $1.56B | $1.58B | $1.57B | $1.56B | $1.56B | $1.56B | $1.56B | $1.56B | $1.56B | · | $1.57B | $1.56B | $1.56B | · | $1.56B | |
| AOCI | $-118M | $-118M | $-116M | $-117M | $-114M | $-124M | $-125M | $-105M | $-117M | $-111M | · | $-109M | $-101M | $-91M | · | $-109M | |
| Stockholders' Equity | $543M | $794M | $805M | $800M | $788M | $754M | $651M | $707M | $686M | $810M | · | $822M | $895M | $893M | · | $842M | |
| Liabilities + Equity | $1.12B | $1.38B | $1.41B | $1.42B | $1.44B | $1.39B | $1.47B | $1.58B | $1.59B | $1.74B | · | $1.79B | $1.89B | $1.82B | · | $1.76B |
Fluxo de Caixa
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $13M | $12M | $13M | $12M | $13M | $14M | $16M | $17M | $18M | $18M | $19M | $18M | $17M | $17M | $19M | $18M | |
| Stock-based Comp | $1M | $4M | $3M | $6M | $6M | $9M | $3M | $3M | $4M | $4M | $3M | $4M | $5M | $4M | $3M | $3M | |
| Other Non-cash | · | $-22M | · | · | · | $-131M | · | · | · | $-19M | · | · | · | $-54M | · | · | |
| Operating Cash Flow | $11M | $-4M | $17M | $27M | $36M | $389.0K | $26M | $31M | $51M | $3M | $54M | $51M | $36M | $-22M | $26M | $28M | |
| CapEx | $6M | $14M | $11M | $10M | $18.0K | $14M | $13M | $9M | $8M | $12M | $20M | $12M | $15M | $11M | $14M | $25M | |
| Investing Cash Flow | $-6M | $-14M | $-10M | $-10M | $9M | $182M | $-14M | $-7M | $-9M | $-9M | $-15M | $-12M | $-93M | $-15M | $-13M | $-25M | |
| Debt Issued | $0 | $225M | $0 | $40M | $15M | $0 | $0 | $15M | $0 | $0 | $0 | $0 | $90M | $20M | $0 | $0 | |
| Net Debt Issued | · | $0 | · | · | · | $-155M | · | · | · | $-20M | · | · | · | $18M | · | · | |
| Stock Repurchased | $0 | $5M | $10M | $5M | $0 | $5M | $0 | $0 | $0 | $0 | $0 | $13M | $0 | $0 | $10M | $40M | |
| Net Stock Activity | · | $-5M | · | · | · | $-5M | · | · | · | · | · | · | · | $0 | · | · | |
| Dividends Paid | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $19M | $19M | $19M | $19M | $19M | $19M | |
| Financing Cash Flow | $-13M | $-20M | $-19M | $-27M | $9M | $-166M | $-44M | $-29M | $-29M | $-32M | $-20M | $-38M | $68M | $1M | $-51M | $-61M | |
| Net Change in Cash | $-9M | $-40M | $-13M | $-12M | $60M | $17M | $-41M | $4M | $12M | $-44M | $23M | $-2M | $6M | $-35M | $-29M | $-70M | |
| Free Cash Flow | · | $-18M | · | · | · | $-13M | · | · | · | $-9M | · | · | · | $-34M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-5M | · | · | · | · | · | · |
Lucratividade
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 68.2% | 66.9% | · | 70.5% | 68.8% | 67.8% | · | 70.1% | 70.0% | 70.5% | · | 58.6% | 72.9% | 72.2% | · | 67.7% | |
| Operating Margin | -18.5% | 1.3% | · | 5.9% | 8.0% | -2.7% | · | 4.2% | -28.6% | 2.1% | · | -5.3% | 8.5% | 3.3% | · | -3.8% | |
| Net Margin | -78.0% | 0.57% | · | 4.7% | 5.5% | 29.5% | · | 1.9% | -26.9% | -0.13% | · | -7.4% | 5.4% | 2.4% | · | -4.7% | |
| Pretax Margin | -19.7% | 0.81% | · | 4.4% | 7.1% | 36.9% | · | 3.1% | -30.0% | 0.26% | · | -6.9% | 7.4% | 3.0% | · | -5.4% | |
| EBITDA Margin | -14.6% | 5.1% | · | 9.3% | 11.3% | 1.2% | · | 8.3% | -24.6% | 6.5% | · | -1.6% | 11.9% | 6.9% | · | -0.39% | |
| ROA | -19.5% | 0.13% | · | 1.1% | 1.4% | 6.9% | · | 0.49% | -6.8% | -0.03% | · | -2.1% | 1.4% | 0.61% | · | -1.4% | |
| ROE | -37.5% | 0.24% | · | 2.3% | 2.9% | 13.8% | · | 1.1% | -15.0% | -0.06% | · | -4.4% | 2.9% | 1.2% | · | -2.9% | |
| ROIC | -31.0% | 0.28% | · | 2.2% | 2.3% | -0.80% | · | 1.0% | -9.8% | -0.33% | · | -2.1% | 2.2% | 0.95% | · | -1.4% |
Liquidez e Solvência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 2.0 | · | 2.2 | 2.0 | 2.0 | · | 1.9 | 2.1 | 2.1 | · | 1.6 | 1.8 | 2.1 | · | 2.1 | |
| Quick Ratio | 0.9 | 1.0 | · | 1.2 | 1.1 | 1.0 | · | 0.9 | 1.0 | 0.9 | · | 0.8 | 0.7 | 0.8 | · | 1.0 | |
| Debt / Equity | 0.4 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.6 | 0.7 | 0.6 | · | 0.6 | 0.6 | 0.5 | · | 0.5 | |
| LT Debt / Equity | 0.4 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.5 | 0.6 | 0.6 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | 2.8 | -18.7 | 1.2 | · | · | · | · | · | · |
Eficiência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Inventory Turnover | 0.5 | 0.6 | · | 0.5 | 0.6 | 0.5 | · | 0.5 | 0.4 | 0.4 | · | 0.7 | 0.4 | 0.4 | · | 0.5 | |
| Receivables Turnover | 5.9 | 6.3 | · | 6.2 | 5.9 | 5.9 | · | 5.9 | 6.3 | 6.6 | · | 8.0 | 9.0 | 8.6 | · | 10.7 |
Por Ação
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $6.59 | $6.49 | · | $7.24 | $7.80 | $7.24 | · | $8.65 | $8.84 | $8.42 | · | $10.00 | $9.97 | $9.62 | · | $10.71 | |
| Cash Flow / Share | · | $-0.08 | · | · | · | $0.01 | · | · | · | $0.07 | · | · | · | $-0.44 | · | · | |
| EPS (TTM) | $-4.49 | $1.08 | · | $2.18 | $2.01 | $-0.80 | · | $-2.08 | $-2.99 | $-0.07 | · | $1.18 | $1.41 | $1.54 | · | $0.75 |
Avaliação (TTM)
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.38B | $1.44B | · | $1.56B | $1.63B | $1.68B | · | $1.78B | $1.84B | $1.90B | · | $2.00B | $2.04B | $2.10B | · | $2.38B | |
| Net Income TTM | $-216M | $55M | · | $110M | $101M | $-39M | · | $-103M | $-148M | $-3M | · | $59M | $70M | $77M | · | $38M | |
| P/E | -1.2 | 6.7 | · | 5.6 | 4.0 | -9.1 | · | -3.5 | -3.5 | -197.6 | · | 18.0 | 23.5 | 25.5 | · | 44.5 | |
| Earnings Yield | -85.0% | 14.8% | · | 17.9% | 25.2% | -11.0% | · | -28.2% | -28.4% | -0.51% | · | 5.6% | 4.2% | 3.9% | · | 2.2% | |
| Payout Ratio | · | 156.5% | · | · | · | 2.8% | · | · | · | -558.9% | · | · | · | 170.5% | · | · | |
| Annual Payout | $12M | $12M | · | $12M | $12M | $12M | · | $28M | $45M | $61M | · | $77M | $77M | $77M | · | $77M |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Receita | $1.49B | $1.73B | $1.97B | $2.23B | $2.70B |
| Margem Bruta % | 69.5% | 68.2% | 68.9% | 71.7% | 75.0% |
| Margem Operacional % | 4.4% | -8.8% | 2.5% | 5.0% | 8.7% |
| Lucro líquido | $160M | $-147M | $9M | $105M | $147M |
| EPS Diluído | $3.18 | $-2.95 | $0.17 | $2.07 | $2.86 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | 0.3 | 0.6 | 0.6 | 0.4 | 0.4 |
| Índice de liquidez corrente | 2.1 | 1.8 | 2.1 | 2.1 | 1.6 |
| Índice de Liquidez Seca | 1.1 | 0.8 | 1.0 | 0.9 | 0.7 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $46M | $70M | $60M | $49M | $73M |
Investidores institucionais (13F) 183 declarantes · $241.8M total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 28 (+2 vs trimestre anterior) | 35 (+9 vs trimestre anterior) | 52 (-13 vs trimestre anterior) | 60 (-4 vs trimestre anterior) | -182K |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $41.729.944 | 4.337.832 | 17,26% | Ações |
| BlackRock, Inc. | $22.787.834 | 4.315.878 | 9,42% | Ações |
| AMERICAN CENTURY COMPANIES INC | $12.150.906 | 2.301.308 | 5,02% | Ações |
| Coppell Advisory Solutions LLC | $11.266.612 | 235 | 4,66% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $10.822.104 | 2.049.641 | 4,47% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $9.486.817 | 1.796.745 | 3,92% | Ações |
| Prescott Group Capital Management, L.L.C. | $9.475.530 | 1.794.608 | 3,92% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $9.170.600 | 1.736.856 | 3,79% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $8.488.614 | 1.607.692 | 3,51% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7.671.507 | 1.452.937 | 3,17% | Ações |
| CastleKnight Management LP | $7.337.262 | 1.389.633 | 3,03% | Ações |
| TWO SIGMA ADVISERS, LP | $7.314.086 | 760.300 | 3,02% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $6.702.971 | 1.269.191 | 2,77% | Ações |
| TWO SIGMA INVESTMENTS, LP | $6.170.388 | 1.168.634 | 2,55% | Ações |
| STATE STREET CORP | $5.330.941 | 1.009.648 | 2,20% | Ações |
| PRUDENTIAL FINANCIAL INC | $4.890.795 | 926.287 | 2,02% | Ações |
| MORGAN STANLEY | $4.781.192 | 905.527 | 1,98% | Ações |
| AQR CAPITAL MANAGEMENT LLC | $4.024.565 | 789.131 | 1,66% | Ações |
| CITADEL ADVISORS LLC | $3.456.167 | 654.577 | 1,43% | Ações |
| GOLDMAN SACHS GROUP INC | $3.266.432 | 618.642 | 1,35% | Ações |
| Bank of New York Mellon Corp | $2.862.799 | 542.197 | 1,18% | Ações |
| NORTHERN TRUST CORP | $2.191.300 | 415.019 | 0,91% | Ações |
| Allianz Asset Management GmbH | $2.074.074 | 392.817 | 0,86% | Ações |
| D. E. Shaw & Co., Inc. | $2.010.043 | 380.690 | 0,83% | Ações |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1.674.151 | 317.074 | 0,69% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $1.627.908 | 308.316 | 0,67% | Ações |
| Connor, Clark & Lunn Investment Management Ltd. | $1.590.690 | 301.267 | 0,66% | Ações |
| Empowered Funds, LLC | $1.321.542 | 250.292 | 0,55% | Ações |
| AXA Investment Managers S.A. | $1.307.268 | 107.241 | 0,54% | Ações |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $1.212.651 | 166.573 | 0,50% | Ações |
| STATE OF WISCONSIN INVESTMENT BOARD | $1.081.872 | 204.900 | 0,45% | Ações |
| Nuveen, LLC | $951.700 | 180.246 | 0,39% | Ações |
| Vanguard Global Advisers, LLC | $936.603 | 177.387 | 0,39% | Ações |
| FIRST TRUST ADVISORS LP | $925.594 | 175.302 | 0,38% | Ações |
| Russell Investments Group, Ltd. | $888.036 | 168.189 | 0,37% | Ações |
| XTX Topco Ltd | $823.379 | 155.943 | 0,34% | Ações |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $803.590 | 152.195 | 0,33% | Ações |
| MARTINGALE ASSET MANAGEMENT L P | $799.852 | 151.487 | 0,33% | Ações |
| JPMORGAN CHASE & CO | $751.441 | 142.588 | 0,31% | Ações |
| LAZARD ASSET MANAGEMENT LLC | $728.614 | 137.995 | 0,30% | Ações |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $670.856 | 127.056 | 0,28% | Ações |
| UBS Group AG | $647.482 | 122.629 | 0,27% | Ações |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $628.125 | 118.963 | 0,26% | Ações |
| ExodusPoint Capital Management, LP | $616.408 | 116.744 | 0,25% | Ações |
| Cubist Systematic Strategies, LLC | $571.087 | 46.849 | 0,24% | Ações |
| RITHOLTZ WEALTH MANAGEMENT | $527.566 | 99.918 | 0,22% | Ações |
| Inspire Investing, LLC | $515.631 | 70.828 | 0,21% | Ações |
| STRS OHIO | $511.104 | 96.800 | 0,21% | Ações |
| ALLIANCEBERNSTEIN L.P. | $467.376 | 64.200 | 0,19% | Ações |
| Nebula Research & Development LLC | $460.288 | 57.608 | 0,19% | Ações |
Ativistas e proprietários de 5%+ 9 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 11 de Fevereiro de 2008 | · | Declaração inicial | · | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 2 de Abril de 2007 | · | Declaração inicial | · | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 26 de Março de 2007 | · | Declaração inicial | · | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 15 de Março de 2007 | · | Declaração inicial | · | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 8 de Dezembro de 2006 | · | Declaração inicial | · | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 9 de Junho de 2006 | · | Declaração inicial | · | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 8 de Maio de 2006 | · | Declaração inicial | · | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 20 de Janeiro de 2006 | · | Declaração inicial | · | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 15 de Dezembro de 2005 | · | Declaração inicial | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Executivos da empresa 57 insiders · 31 diretores · 25 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Ryan S Napierski | President and CEO | 6 de Março de 2026 A | 1.001.905 | 0 | 0 | $0 |
| Ritch N Wood | Chief Executive Officer | 17 de Junho de 2021 S | 175.239 | 0 | 0 | $0 |
| Truman M Hunt | President & CEO | 27 de Fevereiro de 2017 A | 575.559 | 0 | 0 | $0 |
| James D Thomas | Chief Financial Officer | 6 de Março de 2026 A | 267.102 | 0 | 0 | $0 |
| Mark H Lawrence | Chief Financial Officer | 2 de Março de 2023 M | 57.146 | 0 | 0 | $0 |
| Scott E Schwerdt | President, Americas Region | 18 de Dezembro de 2015 A | 34.585 | 0 | 0 | $0 |
| Gary Sumihiro | President | 20 de Dezembro de 2007 A | 800 | 0 | 0 | $0 |
| Luke Loo | President | 20 de Dezembro de 2007 A | 5.625 | 0 | 0 | $0 |
| Larry V Macfarlane | President, Big Planet | 26 de Fevereiro de 2007 A | 6.005 | 0 | 0 | $0 |
| Robert S Conlee | President, North Asia & Japan | 26 de Fevereiro de 2007 A | 4.549 | 0 | 0 | $0 |
| Lori H Bush | President -Nu Skin Division | 31 de Agosto de 2005 A | 11.453 | 0 | 0 | $0 |
| Chayce David Clark | EVP, COO and CLO | 6 de Março de 2026 A | 390.746 | 0 | 0 | $0 |
| Justin S Keisel | EVP, President of Global Sales | 6 de Março de 2026 A | 160.170 | 0 | 0 | $0 |
| Steven Keith Hatchett | Chief Product Officer | 6 de Março de 2026 A | 260.818 | 1 | 0 | $52.855 |
| Connie Mang Yee Tang | Chief Global Growth Officer | 21 de Abril de 2023 F | 43.204 | 0 | 0 | $0 |
| Joseph Y Chang | Chief Scientific Officer | 2 de Março de 2023 M | 21.234 | 0 | 0 | $0 |
| Steven Lund | Exec. Chairman of the Board | 1 de Março de 2023 G | 113.574 | 0 | 0 | $0 |
| Jeffrey Clark Bettinger | SVP, People and Places Officer | 5 de Outubro de 2021 S | 16.068 | 0 | 0 | $0 |
| Matthew D Dorny | General Counsel | 2 de Julho de 2021 M | 47.159 | 0 | 0 | $0 |
| Daniel R Chard | Pres Global Sales & Operations | 6 de Julho de 2015 M | 48.111 | 0 | 0 | $0 |
| Blake Roney | Chairman of the Board | 3 de Junho de 2011 G | 3.216.458 | 0 | 0 | $0 |
| Ashok Pahwa | Chief Marketing Officer | 28 de Agosto de 2009 F | 3.322 | 0 | 0 | $0 |
| Jack Peterson | Vice President | 20 de Dezembro de 2007 A | 6.984 | 0 | 0 | $0 |
| Mark L Adams | Chief Information Officer | 20 de Dezembro de 2007 A | 11.410 | 0 | 0 | $0 |
| Claire Averett | Vice President | 4 de Setembro de 2007 F | 3.230 | 0 | 0 | $0 |
| Brett Nelson | Vice President | 4 de Setembro de 2007 F | 4.202 | 0 | 0 | $0 |
| Corey B Lindley | Executive Vice President | 1 de Setembro de 2006 A | 20.750 | 0 | 0 | $0 |
| Mark Wolfert | Regional Vice President- | 31 de Agosto de 2005 A | 0 | 0 | 0 | $0 |
| Michael D Smith | Vice President-Gov't Relations | 31 de Agosto de 2005 A | 1.734 | 0 | 0 | $0 |
| Richard W King | Chief Information Officer | 31 de Agosto de 2005 A | 5.987 | 0 | 0 | $0 |
| Brooke Roney | Senior Vice President | 2 de Dezembro de 2004 G | 825.000 | 0 | 0 | $0 |
| Edwina D Woodbury | Conselheiro | 9 de Setembro de 2026 A | 62.474 | 0 | 1 | $-41.057 |
| James M Winett | Conselheiro | 2 de Junho de 2026 S | 37.448 | 0 | 1 | $-40.481 |
| Laura Nathanson | Conselheiro | 1 de Junho de 2026 A | 57.116 | 0 | 1 | $-18.009 |
| Emma S. Battle | Conselheiro | 1 de Junho de 2026 A | 57.648 | 0 | 0 | $0 |
| Pisano R. Thomas | Conselheiro | 1 de Junho de 2026 A | 116.827 | 0 | 0 | $0 |
| Mark A Zorko | Conselheiro | 1 de Junho de 2026 A | 60.586 | 0 | 0 | $0 |
| Daniel W Campbell | Conselheiro | 1 de Junho de 2026 A | 65.859 | 0 | 0 | $0 |
| Zheqing Shen | Conselheiro | 7 de Junho de 2024 A | 33.195 | 0 | 0 | $0 |
| Andrew D Lipman | Conselheiro | 28 de Maio de 2024 S | 23.225 | 0 | 0 | $0 |
| Neil H Offen | Conselheiro | 21 de Maio de 2019 M | 10.083 | 0 | 0 | $0 |
| Nevin N Andersen | Conselheiro | 21 de Maio de 2019 M | 34.045 | 0 | 0 | $0 |
| Zhequing Shen | Conselheiro | 11 de Maio de 2017 A | 3.456 | 0 | 0 | $0 |
| Patricia Negron | Conselheiro | 13 de Maio de 2015 G | 7.592 | 0 | 0 | $0 |
| Sandra Tillotson | Conselheiro | 4 de Maio de 2012 M | 1.885.845 | 0 | 0 | $0 |
| David D. Ussery | Conselheiro | 9 de Fevereiro de 2012 M | 13.222 | 0 | 0 | $0 |
| Ej Jake Garn | Conselheiro | 24 de Maio de 2011 A | 17.272 | 0 | 0 | $0 |
| Desmond C Wong | Conselheiro | 15 de Maio de 2007 A | 1.400 | 0 | 0 | $0 |
| Christine Mccormick Day | Conselheiro | 15 de Maio de 2007 A | 1.400 | 0 | 0 | $0 |
| Allen D Andersen | Conselheiro | 25 de Maio de 2006 A | 2.500 | 0 | 0 | $0 |
| Paula Hawkins | Conselheiro | 25 de Maio de 2006 A | · | 0 | 0 | $0 |
| Jose Ferreira JR | Conselheiro | 25 de Maio de 2006 A | · | 0 | 0 | $0 |
| Nancy Roney | Detentor de 10% | 3 de Dezembro de 2004 G | 8.541.469 | 0 | 0 | $0 |
| Nedra D Roney | Detentor de 10% | 27 de Outubro de 2003 S | 1.845.765 | 0 | 0 | $0 |
| Andrew Fan | · | 20 de Dezembro de 2007 A | 22.815 | 0 | 0 | $0 |
| Melisa Quijano | · | 4 de Setembro de 2007 A | 6.901 | 0 | 0 | $0 |
| Takashi Bamba | · | 2 de Setembro de 2003 A | · | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 24 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| MYLD · Cambria ETF Trust | 0,99% | 64.849 NS | 31 de Julho de 2026 | N-PORT |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,11% | 122.929 NS | 31 de Julho de 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,08% | 123.628 SH | 19 de Agosto de 2026 | Diário |
| VFQY · VANGUARD WELLINGTON FUND | 0,06% | 51.988 SH | 19 de Agosto de 2026 | Diário |
| IWC · iShares Trust | 0,06% | 166.825 SH | 11 de Setembro de 2026 | Diário |
| VDC · VANGUARD WORLD FUND | 0,03% | 570.468 SH | 19 de Agosto de 2026 | Diário |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 42.579 SH | 19 de Agosto de 2026 | Diário |
| EBIT · Harbor ETF Trust | 0,02% | 424 NS | 31 de Julho de 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,01% | 220.644 NS | 31 de Julho de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 280.867 SH | 19 de Agosto de 2026 | Diário |
| IWM · iShares Trust | 0,01% | 1.309.534 SH | 11 de Setembro de 2026 | Diário |
| RSSL · Global X Funds | 0,01% | 23.316 NS | 31 de Julho de 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,00% | 125.157 NS | 31 de Julho de 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,00% | 34.871 SH | 1 de Outubro de 2026 | Diário |
| DFAS · Dimensional ETF Trust | 0,00% | 42.209 NS | 31 de Julho de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 4.155 NS | 31 de Julho de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 69.540 SH | 11 de Setembro de 2026 | Diário |
| IWV · iShares Trust | 0,00% | 12.201 SH | 3 de Setembro de 2026 | Diário |
| DFUS · Dimensional ETF Trust | 0,00% | 9.320 NS | 31 de Julho de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 562.165 SH | 19 de Agosto de 2026 | Diário |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.465.550 SH | 19 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.734 SH | 19 de Agosto de 2026 | Diário |
| IWN · iShares Trust | · | 494.441 SH | 11 de Setembro de 2026 | Diário |
| SMLF · iShares Trust | · | 109.833 SH | 11 de Setembro de 2026 | Diário |
NUS Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
Preço-alvo de 12 meses
1 analistas · 2026-10-01Alvo médio $12.77 +177,0%
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| NUS | · | 3.0 | -14.3% | 10.8% | 22.0% | 69.5% |
| HNST | $291M | -18.4 | -1.9% | -4.2% | -8.8% | 33.3% |
| USNA | $355M | 33.5 | 8.3% | 1.2% | 2.0% | 78.3% |
| NATR | $378M | 20.4 | 5.7% | 4.1% | 12.0% | 72.4% |
| NAGE | $507M | 31.8 | 29.9% | 13.4% | 24.7% | 64.3% |
| MED | $117M | -6.3 | -36.0% | -4.8% | -9.0% | 71.3% |
Últimas notícias Notícias recentes mencionando esta empresa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.